LIFECORE BIOMEDICAL, INC. Stock Repurchased During Period, Shares
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- LIFECORE BIOMEDICAL, INC. stock repurchased during period, shares for the quarter ending 2023-05-28 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. stock repurchased during period, shares for the quarter ending 2023-02-26 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. stock repurchased during period, shares for the quarter ending 2022-11-27 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. stock repurchased during period, shares for the quarter ending 2022-08-28 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. stock repurchased during period, shares for fiscal 2024 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. stock repurchased during period, shares for fiscal 2023 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. stock repurchased during period, shares for fiscal 2022 was 0.00 shares.
- LIFECORE BIOMEDICAL, INC. stock repurchased during period, shares for fiscal 2021 was 0.00 shares.
| Period end | Stock Repurchased During Period, Shares 3 month | Stock Repurchased During Period, Shares 12 month |
|---|---|---|
| 2024-05-26 | 0.00 shares 10-K · filed 2024-08-26 | |
| 2023-05-28 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | 0.00 shares 10-K · filed 2024-08-26 |
| 2023-02-26 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-02 | 0.00 shares derived: sum of 4 quarters · filed 2024-08-26 |
| 2022-11-27 | 0.00 shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-03-16 | 0.00 shares derived: sum of 4 quarters · filed 2024-08-26 |
| 2022-08-28 | 0.00 shares 10-Q/A · filed 2023-03-16 | 0.00 shares derived: sum of 4 quarters · filed 2024-08-26 |
| 2022-05-29 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | 0.00 shares 10-K · filed 2024-08-26 |
| 2022-02-27 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-02 | |
| 2021-11-28 | 0.00 shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-03-16 | |
| 2021-08-29 | 0.00 shares 10-Q/A · filed 2023-03-16 | |
| 2021-05-30 | 0.00 shares 10-K · filed 2024-03-20 | |
| 2020-05-31 | 0.00 shares 10-K/A · filed 2023-03-16 | |
| 2019-05-26 | 0.00 shares 10-K · filed 2021-07-29 | |
| 2018-05-27 | 0.00 shares 10-K · filed 2020-08-14 | |
| 2014-11-30 | 0.00 shares 10-Q · filed 2015-01-09 | |
| 2014-08-31 | 0.00 shares 10-Q · filed 2014-10-08 | |
| 2014-02-23 | 0.00 shares 10-Q · filed 2014-03-28 | |
| 2013-11-24 | 0.00 shares 10-Q · filed 2014-01-03 | |
| 2013-08-25 | 0.00 shares 10-Q · filed 2013-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |